A Multicenter Cohort Study From India of ABO-Incompatible Kidney Transplantation in Post–COVID-19 Patients

[1]  A. Gingras,et al.  Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine , 2021, Annals of Internal Medicine.

[2]  L. Rostaing,et al.  Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response , 2021, Journal of clinical medicine.

[3]  V. Siddini,et al.  Effect of Coronavirus Disease 2019 on Transplantation and Nephrology in India: A Nationwide Report From India , 2021, Transplantation Proceedings.

[4]  J. Schold,et al.  COVID-19–Associated Mortality among Kidney Transplant Recipients and Candidates in the United States , 2021, Clinical journal of the American Society of Nephrology : CJASN.

[5]  C. Hirzel,et al.  Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study , 2021, The Lancet Rheumatology.

[6]  C. Jacquelinet,et al.  COVID-19 pandemic and worldwide organ transplantation: a population-based study , 2021, The Lancet Public Health.

[7]  O. Manuel,et al.  SARS‐CoV‐2 vaccination in solid‐organ transplant recipients: What the clinician needs to know , 2021, Transplant international : official journal of the European Society for Organ Transplantation.

[8]  V. Siddini,et al.  Is Early COVID-19 in Kidney Transplant Recipients Concerning Enough to Halt Transplantation? A Multicenter Comparative Analysis from India , 2021, Transplantation Proceedings.

[9]  D. Sanchez-Ramirez,et al.  Long-Term Impact of COVID-19: A Systematic Review of the Literature and Meta-Analysis , 2021, Biomedicines.

[10]  D. Segev,et al.  Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. , 2021, JAMA.

[11]  N. Prasad,et al.  ISOT Consensus Statement for the Kidney Transplant Recipient and Living Donor with a Previous Diagnosis of COVID-19 , 2021, Indian journal of nephrology.

[12]  E. Corruble,et al.  Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. , 2021, JAMA.

[13]  T. Vannorsdall,et al.  Post‐acute cognitive and mental health outcomes amongst COVID‐19 survivors: early findings and a call for further investigation , 2021, Journal of internal medicine.

[14]  Seoung Woo Lee,et al.  Effect of rituximab dose on induction therapy in ABO-incompatible living kidney transplantation , 2021, Medicine.

[15]  V. Siddini,et al.  A Multicenter Cohort Study From India of 75 Kidney Transplants in Recipients Recovered After COVID-19 , 2021, Transplantation.

[16]  P. Molyneaux,et al.  Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment , 2021, Annals of the American Thoracic Society.

[17]  Guohui Fan,et al.  RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2021, The Lancet.

[18]  N. Kamar,et al.  Is COVID-19 infection more severe in kidney transplant recipients? , 2020, American Journal of Transplantation.

[19]  M. Schnitzler,et al.  An International survey on living kidney donation and transplant practices during the COVID‐19 pandemic , 2020, Transplant infectious disease : an official journal of the Transplantation Society.

[20]  E. Akalin,et al.  Covid-19 and Solid Organ Transplantation: A Review Article. , 2020, Transplantation.

[21]  F. Moreso,et al.  COVID-19 in transplant recipients: The Spanish experience , 2020, American Journal of Transplantation.

[22]  Seoung Woo Lee,et al.  EFFECT OF RITUXIMAB DOSE AS INDUCTION THERAPY IN ABO-INCOMPATIBLE LIVING KIDNEY TRANSPLANTATION: A NETWORK META-ANALYSIS , 2020 .

[23]  Seoung Woo Lee,et al.  Effect of Rituximab Used as Induction in Patients with ABO Mismatch Kidney Transplant: A Systematic Review and Meta-analysis. , 2020, Transplantation proceedings.

[24]  S. Agarwal,et al.  Renal Transplant Guidelines with Reference to COVID-19 Infection , 2020, Indian journal of nephrology.

[25]  H. Haller,et al.  Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis , 2019, The Lancet.

[26]  Jae Geun Lee,et al.  The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.